These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28057790)

  • 21. Circulating microRNAs in Cardiovascular Diseases.
    Orlicka-Płocka M; Gurda D; Fedoruk-Wyszomirska A; Smolarek I; Wyszko E
    Acta Biochim Pol; 2016; 63(4):725-729. PubMed ID: 27755614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between inflammatory and oxidative stress biomarkers, atherosclerosis and rheumatic diseases.
    Şerban C; Drăgan S
    Curr Pharm Des; 2014; 20(4):585-600. PubMed ID: 23565633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension.
    Rizzo M; Corrado E; Coppola G; Muratori I; Novo G; Novo S
    Coron Artery Dis; 2009 Jan; 20(1):15-20. PubMed ID: 19060627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
    Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
    Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developing and assessing cardiovascular biomarkers.
    Dadu RT; Nambi V; Ballantyne CM
    Transl Res; 2012 Apr; 159(4):265-76. PubMed ID: 22424430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular disease in patients with inflammatory bowel disease: An issue in no guidelines land.
    Zuin M; Rigatelli G; Del Favero G; Andreotti AN; Picariello C; Zuliani G; Carraro M; Galasso MP; Roncon L
    Int J Cardiol; 2016 Nov; 222():984-985. PubMed ID: 27526375
    [No Abstract]   [Full Text] [Related]  

  • 28. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.
    Kondkar AA; Abu-Amero KK
    Biomed Res Int; 2015; 2015():821823. PubMed ID: 25710029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin cholesterol: test performance, evaluation of potential determinants and correlation analysis with cardiovascular risk factors and circulating markers of inflammation.
    Reiter M; Wirth S; Pourazim A; Exner M; Baghestanian M; Rumpold H; Minar E; Bucek RA
    Vasa; 2006 Aug; 35(3):167-73. PubMed ID: 16941405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases.
    Battistoni A; Rubattu S; Volpe M
    Int J Cardiol; 2012 May; 157(2):160-8. PubMed ID: 21763018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of reported chest pain for cardiovascular risk stratification in primary care.
    Leistner DM; Klotsche J; Palm S; Pieper L; Stalla GK; Lehnert H; Silber S; März W; Wittchen HU; Zeiher AM;
    Eur J Prev Cardiol; 2014 Jun; 21(6):727-38. PubMed ID: 22739685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review on cardiovascular risk prediction.
    Ruwanpathirana T; Owen A; Reid CM
    Cardiovasc Ther; 2015 Apr; 33(2):62-70. PubMed ID: 25758853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Asymmetric dimethylarginine: predictor of cardiovascular diseases?].
    Németh B; Kustán P; Németh Á; Lenkey Z; Cziráki A; Kiss I; Sulyok E; Ajtay Z
    Orv Hetil; 2016 Mar; 157(13):483-7. PubMed ID: 26996894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnostic utility of cardiac biomarkers in dialysis patients.
    Wang AY; Wai-Kei Lam C
    Semin Dial; 2012 Jul; 25(4):388-96. PubMed ID: 22748194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation.
    Roldán V; Arroyo AB; Salloum-Asfar S; Manzano-Fernández S; García-Barberá N; Marín F; Vicente V; González-Conejero R; Martínez C
    Thromb Haemost; 2014 Oct; 112(4):781-8. PubMed ID: 25008481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs Determining Inflammation as Novel Biomarkers and Potential Therapeutic Targets.
    Kotsinas A; Sigala F; Garbis SD; Galyfos G; Filis K; Vougas K; Papalampros A; Johnson EE; Chronopoulos E; Georgakilas AG; Gorgoulis VG
    Curr Med Chem; 2015; 22(22):2666-79. PubMed ID: 26180004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serum albumin and cardiovascular diseases: A comprehensive review of the literature].
    Arques S
    Ann Cardiol Angeiol (Paris); 2018 Apr; 67(2):82-90. PubMed ID: 29544976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel systemic cardiovascular disease biomarkers.
    Bonaterra GA; Zügel S; Kinscherf R
    Curr Mol Med; 2010 Mar; 10(2):180-205. PubMed ID: 20196728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating miRNAs: messengers on the move in cardiovascular disease.
    Egea V; Schober A; Weber C
    Thromb Haemost; 2012 Oct; 108(4):590-1. PubMed ID: 22955179
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T.
    Sommerer C; Giannitsis E; Schwenger V; Zeier M
    Nephron Clin Pract; 2007; 107(3):c77-81. PubMed ID: 17890874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.